The Latest Breaking News from Moderna

Poland can compromise with Moderna Inc (NASDAQ:MRNA) on increasing the flexibility of COVID-19 vaccine contracts, Reuters reported citing the health minister, striking an upbeat tone after initial talks with the company. Poland has said it will not take or pay for more doses of the COVID-19 vaccine under the European Union's supply contract.  Reuters…

Shares of vaccine companies, including Moderna Inc (NASDAQ: MRNA), are trading higher amid COVID-19 concerns due to rising cases in China.

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The hunt continues at a brisk pace thanks to rapid developments in generating more potent computing power, writes Kumitaa Theva Das in part three in a series on vaccines beyond Covid.

Ashish Jha says spreading variant unlikely to have much effect on the nation’s pandemic recovery

COVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster

Deaths involving Covid-19 are up 13 per cent on last week, the latest data shows

'The longer-term protection against hospitalisation and death is perhaps the most important factor for future booster programmes'

The study compared immune responses to seven vaccines used as a booster 28 days after two initial doses.

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

The demise of the federal transportation mask mandate was particularly jarring for many parents of children under five anxiously waiting for word on when COVID shots will become available to their kids.